NASDAQ: NPCENeuropace Inc Stock Ownership - Who owns Neuropace?
Insider buying vs selling
Have Neuropace Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Rakhi Kumar | Director | 2025-09-19 | 1,509 | $9.94 | $15.00kBuy |
| Joseph Lacob | Director | 2025-09-19 | 1,131 | $9.94 | $11.24kBuy |
| URI Geiger | Director | 2025-09-19 | 1,194 | $9.94 | $11.87kBuy |
| Frank M. Fischer | Director | 2025-09-19 | 2,389 | $9.94 | $23.75kBuy |
| Martha Morrell | CHIEF MEDICAL OFFICER | 2025-09-03 | 1,337 | $9.36 | $12.51kSell |
| Martha Morrell | CHIEF MEDICAL OFFICER | 2025-08-27 | 357 | $8.88 | $3.17kSell |
| Joel Becker | CHIEF EXECUTIVE OFFICER | 2025-08-27 | 1,126 | $8.88 | $10.00kSell |
| Martha Morrell | CHIEF MEDICAL OFFICER | 2025-08-20 | 3,052 | $8.66 | $26.43kSell |
| Frank M. Fischer | Director | 2025-06-21 | 2,281 | $10.41 | $23.75kBuy |
| URI Geiger | Director | 2025-06-21 | 1,140 | $10.41 | $11.87kBuy |
NPCE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NPCE insiders and whales buy or sell their stock.
NPCE Shareholders
What type of owners hold Neuropace Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| URI Geiger | 26.84% | 8,879,126 | $83.46M | Insider |
| Greg Shaw Garfield | 17.09% | 5,653,237 | $53.14M | Insider |
| Accelmed Partners II LP | 13.40% | 4,432,948 | $41.67M | Insider |
| Evan Norton | 12.22% | 4,042,657 | $38.00M | Insider |
| Orbimed Advisors LLC | 10.50% | 3,473,199 | $32.65M | Insider |
| Orbimed Advisors LLC | 7.90% | 2,614,184 | $24.57M | Institution |
| Morgan Stanley | 7.81% | 2,585,073 | $24.30M | Institution |
| Blackrock Inc | 7.01% | 2,319,166 | $21.80M | Institution |
| Soleus Capital Management LP | 6.99% | 2,312,957 | $21.74M | Institution |
| First Light Asset Management LLC | 4.17% | 1,380,410 | $12.98M | Institution |
NPCE vs Medical Device Stocks
Neuropace Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.